CUSIP No. 09622L102


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  SCHEDULE 13D

                    UNDER THE SECURITIES EXCHANGE ACT OF 1934

                          BLUEFIRE ETHANOL FUELS, INC.

                                (NAME OF ISSUER)

                                  COMMON STOCK,

                         (TITLE OF CLASS OF SECURITIES)

                                    09622L102

                                 (CUSIP NUMBER)

                            JOSEPH P. BARTLETT, ESQ.
                GREENBERG GLUSKER FIELDS CLAMAN & MACHTINGER LLP
                      1900 AVENUE OF THE STARS, SUITE 2100
                              LOS ANGELES, CA 90067
                                 (310) 201-7481

   (Name, Address and Telephone Number of Person Authorized to Receive Notices
                               and Communications)

                                December 14, 2007
             (Date of Event which Requires Filing of this Statement)

If the reporting person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g),
check the following box / /.

NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7(b) for
other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).



CUSIP No. 09622L102

--------------------------------------------------------------------------------
1.   Name of Reporting Persons.
     I.R.S. Identification Nos. of above persons (entities only).

     David Gelbaum, Trustee, The Quercus Trust
--------------------------------------------------------------------------------
2.   Check the Appropriate Box If a Member of a Group (See Instructions)
     (a)  [X]
     (b)  [_]
--------------------------------------------------------------------------------
3.   SEC Use Only

--------------------------------------------------------------------------------
4.   Source of Funds (See Instructions)
     PF
--------------------------------------------------------------------------------
5.   Check If Disclosure of Legal Proceedings Is Required Pursuant to
     Items 2(d) or 2(e)                                             [_]

--------------------------------------------------------------------------------
6.   Citizenship or Place of Organization
     U.S.
--------------------------------------------------------------------------------
               7.   Sole Voting Power
  NUMBER OF         -0-
   SHARES      -----------------------------------------------------------------
BENEFICIALLY   8.   Shared Voting Power
 OWNED BY           11,111,110
    EACH       -----------------------------------------------------------------
  REPORTING    9.   Sole Dispositive Power
   PERSON           -0-
    WITH       -----------------------------------------------------------------
               10.  Shared Dispositive Power
                    11,111,110
--------------------------------------------------------------------------------
11.  Aggregate Amount Beneficially Owned by Each Reporting Person
     11,111,110
--------------------------------------------------------------------------------
12.  Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares
     (See Instructions)                                               [_]
--------------------------------------------------------------------------------
13.  Percent of Class Represented by Amount in Row (11)
     33.1%(1)
--------------------------------------------------------------------------------
14.  Type of Reporting Person (See Instructions)
     IN
--------------------------------------------------------------------------------

_____________
(1)    Based on 33,600,732 shares of Common Stock, par value $0.001 per share
       ("Common Stock") outstanding, calculated in accordance with Rule 13d.


                                       2

CUSIP No. 09622L102

--------------------------------------------------------------------------------
1.   Name of Reporting Persons.
     I.R.S. Identification Nos. of above persons (entities only).

     Monica Chavez Gelbaum, Trustee, The Quercus Trust
--------------------------------------------------------------------------------
2.   Check the Appropriate Box If a Member of a Group (See Instructions)
     (a)  [X]
     (b)  [_]
--------------------------------------------------------------------------------
3.   SEC Use Only

--------------------------------------------------------------------------------
4.   Source of Funds (See Instructions)
     PF
--------------------------------------------------------------------------------
5.   Check If Disclosure of Legal Proceedings Is Required Pursuant to
     Items 2(d) or 2(e)                                             [_]

--------------------------------------------------------------------------------
6.   Citizenship or Place of Organization
     U.S.
--------------------------------------------------------------------------------
               7.   Sole Voting Power
  NUMBER OF         -0-
   SHARES      -----------------------------------------------------------------
BENEFICIALLY   8.   Shared Voting Power
 OWNED BY           11,111,110
    EACH       -----------------------------------------------------------------
  REPORTING    9.   Sole Dispositive Power
   PERSON           -0-
    WITH       -----------------------------------------------------------------
               10.  Shared Dispositive Power
                    11,111,110
--------------------------------------------------------------------------------
11.  Aggregate Amount Beneficially Owned by Each Reporting Person
     11,111,110
--------------------------------------------------------------------------------
12.  Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares
     (See Instructions)                                               [_]
--------------------------------------------------------------------------------
13.  Percent of Class Represented by Amount in Row (11)
     33.1%(1)
--------------------------------------------------------------------------------
14.  Type of Reporting Person (See Instructions)
     IN
--------------------------------------------------------------------------------
______________________
(1)    Based on 33,600,732 shares of Common Stock, par value $0.001 per share
       ("Common Stock") outstanding, calculated in accordance with Rule 13d.


                                       3

CUSIP No. 09622L102

--------------------------------------------------------------------------------
1.   Name of Reporting Persons.
     I.R.S. Identification Nos. of above persons (entities only).

     The Quercus Trust
--------------------------------------------------------------------------------
2.   Check the Appropriate Box If a Member of a Group (See Instructions)
     (a)  [X]
     (b)  [_]
--------------------------------------------------------------------------------
3.   SEC Use Only

--------------------------------------------------------------------------------
4.   Source of Funds (See Instructions)
     PF
--------------------------------------------------------------------------------
5.   Check If Disclosure of Legal Proceedings Is Required Pursuant to
     Items 2(d) or 2(e)                                             [_]

--------------------------------------------------------------------------------
6.   Citizenship or Place of Organization
     U.S.
--------------------------------------------------------------------------------
               7.   Sole Voting Power
  NUMBER OF         -0-
   SHARES      -----------------------------------------------------------------
BENEFICIALLY   8.   Shared Voting Power
 OWNED BY           11,111,110
    EACH       -----------------------------------------------------------------
  REPORTING    9.   Sole Dispositive Power
   PERSON           -0-
    WITH       -----------------------------------------------------------------
               10.  Shared Dispositive Power
                    11,111,110
--------------------------------------------------------------------------------
11.  Aggregate Amount Beneficially Owned by Each Reporting Person
     11,111,110
--------------------------------------------------------------------------------
12.  Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares
     (See Instructions)                                               [_]
--------------------------------------------------------------------------------
13.  Percent of Class Represented by Amount in Row (11)
     33.1%(1)
--------------------------------------------------------------------------------
14.  Type of Reporting Person (See Instructions)
     OO
--------------------------------------------------------------------------------

____________________
(1)    Based on 33,600,732 shares of Common Stock, par value $0.001 per share
       ("Common Stock") outstanding, calculated in accordance with Rule 13d.


                                       4

CUSIP No. 09622L102

Item 1.  Security and Issuer

       Issuer: BlueFire Ethanol Fuels, Inc.

       Security: Common Stock, par value $0.001 per share ("Common Stock")

Item 2.  Identity and Background

       (a) This Statement is being filed by The Quercus Trust (the "Trust"),
David Gelbaum, an individual, as co-trustee of the Trust, and Monica Chavez
Gelbaum, an individual, as co-trustee of the Trust (collectively, the "Reporting
Persons").

       (b) The Reporting Persons' business address is 1835 Newport Blvd. A109 -
PMB 467, Costa Mesa, California 92627.

       (c) David Gelbaum and Monica Chavez Gelbaum are investors; the Trust is a
revocable trust formed for estate planning purposes.

       (d) None of the Reporting Persons has, during the last five years, been
convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors).

       (e) None of the Reporting Persons has, during the past five years, been a
party to a civil proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject to a judgment,
decree or final order enjoining future violations of, or prohibiting or
mandating activities subject to, federal or state securities laws or finding any
violation with respect to such laws.

       (f) Each of Mr. and Ms. Gelbaum is a citizen of the United States of
America. The Trust is a California statutory trust.

Item 3.  Source and Amount of Funds or Other Consideration

       All shares of Common Stock were purchased using personal funds.

Item 4.  Purpose of Transaction

       The shares of Common Stock were purchased by the Trust for investment
purposes. The Reporting Persons have no plans or proposals which relate to or
which would result in any of the actions specified in clauses (a) through (j) of
Item 4 of Schedule 13D. However, the Reporting Persons retain their rights to
modify their plans with respect to the transactions described in this Schedule
13D, to vote, acquire or dispose of securities of the Issuer and to formulate
plans and proposals which could result in the occurrence of any such events,
subject to applicable laws and regulations.

Item 5.  Interest in Securities of the Issuer

       (a) As of the date of this Schedule 13D, each reporting person
beneficially owns 11,111,110 shares of Common Stock, which are held of record by
the Trust.

       (b) Each of David Gelbaum and Monica Chavez Gelbaum, acting alone, has
the power to exercise voting and investment control over the shares of Common
Stock owned by the Trust.

                                       5

CUSIP No. 09622L102

       (c) Since December 03, 2007, the Trust has purchased shares of Common
Stock as follows:


                Date               Number of Shares          Price Per Share
                ----               ----------------          ---------------
             12/03/2007                 185,185                 $ 2.7000
             12/14/2007                5,370,370                $ 2.7000


              The above reported 5,555,555 shares of Common Stock, with a
       purchase price of $2.70 per share, were acquired through a private sale
       as memorialized in Stock Purchase Agreement dated 12/03/2007 and
       Securities Purchase Agreement dated 12/14/2007 (collectively, the
       "Private Sale") between the Issuer and Reporting Persons. Under the terms
       of the Private Sale, the Issuer also issued to the Reporting Persons
       warrants to purchase 5,555,555 additional shares of Common Stock, with an
       expiration date of 12/14/2012 and exercise price of $2.90 per share,
       subject to adjustment as defined in the Private Sale.

       (d) Not applicable.

       (e) Not applicable.

Item 6.  Contracts, Arrangements, Understandings or Relationships With
         Respect to Securities of the Issuer

       (a) Pursuant to the Power of Attorney filed as Exhibit "B" to Amendment
No. 1 to Schedule 13D filed on August 24, 2007 with respect to the issuer Emcore
Corp., David Gelbaum has been appointed as Monica Chavez Gelbaum's
Attorney-In-Fact.

       (b) Stock Purchase Agreement dated 12/03/2007 between Issuer, Reporting
Persons, and other investors, serving as the first of two tranches in connection
with a single private placement financing in the total amount of $15,000,000.

       (c) Securities Purchase Agreement dated 12/14/2007, between Issuer and
Reporting Persons, serving as the second and final tranche in connection with a
single private placement financing in the total amount of $15,000,000.

Item 7.  Material to Be Filed as Exhibits

       Exhibit A: Agreement Regarding Joint Filing of Schedule 13D.

       Exhibit B: Stock Purchase Agreement

       Exhibit C: Securities Purchase Agreement


                                       6

CUSIP No. 09622L102

SIGNATURE

         After reasonable inquiry and to the best of its knowledge and belief,
each of the undersigned certifies that the information set forth in this
statement is true, complete and correct and agrees that this statement may be
filed jointly with the other undersigned parties.


Dated: January 4, 2008            /s/ David Gelbaum
                                  ----------------------------------------------
                                  David Gelbaum, Co-Trustee of The Quercus Trust



                                  /s/ David Gelbaum, as Attorney-In-Fact for
                                      Monica Chavez Gelbaum
                                  ----------------------------------------------
                                  Monica Chavez Gelbaum, Co-Trustee of The
                                  Quercus Trust



                                  /s/ David Gelbaum
                                  ----------------------------------------------
                                  The Quercus Trust, David Gelbaum, Co-Trustee
                                  of The Quercus Trust


                                       7


CUSIP No. 09622L102


                                    EXHIBIT A

                AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13D
                ------------------------------------------------



         The undersigned agree that the Schedule 13D with respect to the Common
Stock of BlueFire Ethanol Fuels, Inc. is a joint filing being made on their
behalf.


Dated: January 4, 2008            /s/ David Gelbaum
                                  ----------------------------------------------
                                  David Gelbaum, Co-Trustee of The Quercus Trust



                                  /s/ David Gelbaum, as Attorney-In-Fact for
                                      Monica Chavez Gelbaum
                                  ----------------------------------------------
                                  Monica Chavez Gelbaum, Co-Trustee of The
                                  Quercus Trust



                                  /s/ David Gelbaum
                                  ----------------------------------------------
                                  The Quercus Trust, David Gelbaum, Co-Trustee
                                  of The Quercus Trust


CUSIP No. 09622L102

                                   EXHIBIT B

                            STOCK PURCHASE AGREEMENT
                            ------------------------


      THIS STOCK PURCHASE AGREEMENT (this "Agreement") is made as of the 3rd day
of December 2007, by and among BLUEFIRE ETHANOL FUELS, INC., a Nevada
corporation (the "Company") and each of the persons listed on Schedule A hereto
(each an "Investor" and collectively, the "Investors").

      WHEREAS, the Company, Quercus Trust, James G. Speirs and James G. Speirs
SEP IRA (the "New Investors") have agreed to enter into a single private
placement financing to be funded in two tranches occurring on December 3, 2007
and on or around December 10, 2007 (collectively, the "Financing"), whereby the
New Investors will purchase from the Company and the Company will issue to the
New Investors shares of common stock and warrants in the Company for an
aggregate purchase price of $15,500,000;

      WHEREAS, the Company and the Investors desire to fund $1,000,000 of the
Financing herein, whereby the Company will issue to each Investor and each
Investor will purchase form the Company the number of shares of common stock
(the "Shares") set forth opposite such Investor's name on Schedule A hereto.

      NOW, THEREFORE, in consideration of the mutual covenants herein contained,
and for such other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, the parties hereto hereby agree as follows:

      1.    Purchase and Sale of the Shares.

            1.1   Sale of Shares. Subject to the terms and conditions of this
Agreement, at the Closing (as hereafter defined), the Company will issue, sell
and deliver to each Investor, and each Investor will purchase from the Company,
the number of Shares set forth opposite such Investor's name on Schedule A
hereto at a purchase price of $2.70 per share.

            1.2   Issuance of Warrants. Concurrently with the sale of the Shares
by the Company and the purchase of the Shares by the Investors, the Investors
will receive a warrant (the "Warrant") to purchase such number of Shares of
Common Stock of the Company (the "Warrant Shares") as set forth on Schedule A
hereto.

            1.3   Closing. The closing of the purchase and sale of the Shares
(the "Closing") will take place at the offices of Seward & Kissel LLP, located
at One Battery Park Plaza, New York, New York, 10004, at 10:00 am, New York time
on the date hereof or on such other date or at such other place as the parties
hereto shall mutually agree (the date of the Closing is hereinafter referred to
as the "Closing Date"). At the Closing, the Company will deliver to each
Investor a stock certificate or certificates dated the Closing Date for the
number of Shares such Investor has agreed to purchase and registered in such
name and in such denominations as such Investor requests, and such Investor will
pay to the Company the purchase price for such Shares by certified check or wire
transfer of immediately available funds.

      2.    Representations, Warranties and Covenants of the Company. The
Company hereby represents, warrants and covenants to each Investor that:



            2.1   Authority/Capacity. The Company is a corporation duly
organized, validly existing and in good standing under the laws of the state of
Nevada and has all requisite corporate power and authority to execute and
deliver this Agreement and to consummate the transactions contemplated hereby.
The execution, delivery and performance of this Agreement has been duly
authorized by all necessary action on the part of the Company, and constitutes a
legal, valid and binding obligation of the Company, enforceable against the
Company in accordance with its terms, except as such enforceability may be
limited by: (i) applicable bankruptcy, insolvency, reorganization, moratorium or
other similar laws affecting the enforcement of creditors' rights generally; and
(ii) general principles of equity (regardless of whether such enforceability is
considered in a proceeding in equity or at law).

            2.2   The Shares. The Shares, when issued, sold and delivered in
accordance with the terms hereof for the consideration expressed herein, will be
duly and validly issued, fully paid and nonassessable and free and clear of all
liens, security interests, options, charges, pledges and encumbrances.

            2.3   The Warrants. The Warrants when issued and delivered will be
duly and validly issued and will be free of all liens and restrictions on
transfer other than under applicable securities laws..

            2.4   The Warrant Shares. The Warrant Shares have been duly reserved
for issuance by the Company in sufficient number to cover the exercise of all of
the Warrants. The issuance of the Warrant Shares upon exercise of the Warrants
has been duly authorized by the Company and the Warrant Shares when delivered in
accordance with the Warrant, will be validly issued, fully paid and
non-assessable, and free of all liens and restrictions on transfer other than
under applicable securities laws.

            2.5   Securities Law. In reliance on the investment representations
made by the Investors, the offer, issuance, sale and delivery of the Shares and
Warrants, as provided in this Agreement, are exempt from the registration
requirements of the Securities Act of 1933, as amended (the "Securities Act"),
and all applicable state securities laws.

            2.6   Reports; Financial Statements. The Company's Annual Report on
Form 10-KSB for the year ended December 31, 2006 and Quarterly Reports on Form
10-QSB for the quarters ended March 31, 2007, June 30, 2007 and September 30,
2007 (the "Reports") have been filed with the Securities and Exchange Commission
(the "SEC") and the Reports complied in all material respects with the rules of
the SEC applicable to such Reports on the date filed with the SEC, and to the
Company's best knowledge, the Reports did not contain, on the date of filing
with the SEC, any untrue statement of a material fact, or omit to state any
material fact necessary to make the statements therein, in light of the
circumstances in which they were made, not materially misleading. All of the
consolidated financial statements included in the Reports (the "Company
Financial Statements"): (a) have been prepared from and on the basis of, and are
in accordance with, the books and records of the Company and with generally
accepted accounting principles ("GAAP") applied on a basis consistent with prior
accounting periods; (b) fairly and accurately present in all material respects
the consolidated financial condition of the Company as of the date of each such
Company Financial Statement and the results of its operations for the periods
therein specified; and (c) in the case of the annual financial statements, are


                                       2


accompanied by the audit opinion of the Company's independent public
accountants. Except as set forth in the Company Financial Statements, as of the
date hereof, Company has no liabilities other than (x) liabilities which are
reflected or reserved against in the Company Financial Statements and which
remain outstanding and undischarged as of the date hereof, (y) liabilities
arising in the ordinary course of business of the Company since September 30,
2007, or (z) which were not required by generally accepted accounting principles
to be reflected or reserved on the Company Financial Statements. Since September
30, 2007, there has not been any event or change which has had a Material
Adverse Effect (as hereinafter defined) and Company has no actual knowledge of
any event or circumstance that would reasonably be expected to result in such a
Material Adverse Effect. As used herein, "Material Adverse Effect" shall mean a
material adverse effect on (i) the Company, (ii) its consolidated results of
operations, assets, or financial condition, (iii) its ability to perform its
obligations under this Agreement or (iv) the Shares or the Warrant Shares,
PROVIDED HOWEVER, that a Material Adverse Effect shall not include facts,
circumstances, events, changes, effects or occurrences (i) affecting the United
States or global economy or capital or financial markets or the ethanol market
generally which do not materially disproportionately affect the Company, (ii)
resulting from changes in laws, regulations or GAAP, or in the authoritative
interpretations thereof or in regulatory or interpretive guidance related
thereto which do not materially disproportionately affect the Company, (iii)
resulting from earthquakes or similar catastrophes, or acts of war, sabotage,
terrorism, military action or any escalation or worsening thereof which do not
materially disproportionately affect the Company, or (iv) resulting from this
Agreement, the announcement thereof and the transactions contemplated hereby.

      3.    Representations and Warranties of the Investors. Each Investor
hereby severally represents and warrants that:

            3.1   Authority; Capacity to Purchase. If such Investor is an
entity, it is duly organized, validly existing and in good standing under the
laws of its jurisdiction of organization. It has all requisite power and
authority to execute and deliver this Agreement and to consummate the
transactions contemplated hereby. The execution, delivery and performance of
this Agreement has been duly authorized by all necessary action on the part of
such Investor, and constitutes a legal, valid and binding obligation of such
Investor, enforceable against such Investor in accordance with its terms, except
as such enforceability may be limited by: (i) applicable bankruptcy, insolvency,
reorganization, moratorium or other similar laws affecting the enforcement of
creditors' rights generally; and (ii) general principles of equity (regardless
of whether such enforceability is considered in a proceeding in equity or at
law).

            3.2   Securities Law. Each Investor is an "accredited investor" as
defined in Rule 501(a) promulgated under the Securities Act and has such
knowledge and experience in financial and business matters that it is capable of
evaluating the merits and risks of the transactions contemplated under this
Agreement. Such Investor is acquiring the Shares solely for investment purposes,
with no intention of distributing or reselling any of the Shares or any interest
therein. Such Investor's financial condition is such that it is able to bear all
economic risks of investment in the Shares, including a complete loss of its
investment. The Company has provided such Investor with adequate access to
financial and other information concerning the Company as requested and such
Investor has had the opportunity to ask questions of and receive answers from
the Company concerning the transactions contemplated by this Agreement and to


                                       3


obtain therefrom any additional information necessary to make an informed
decision regarding an investment in the Company. Such Investor is aware that the
Shares are not registered under the Securities Act and will be endorsed with
transfer restriction legends, and that neither the Shares nor any interest
therein may be sold, pledged, or otherwise transferred unless the Shares are
registered under the Securities Act or qualify for an exemption under the
Securities Act.

      4.    Miscellaneous.

            4.1   Successors and Assigns. Except as otherwise provided herein,
the terms and conditions of this Agreement shall inure to the benefit of and be
binding upon the respective successors and assigns of the parties.

            4.2   Entire Agreement. This Agreement constitutes the full and
entire understanding and agreement between the parties hereto with respect to
the subject matter hereof and supersedes all prior agreements, written or oral,
with respect thereto.

            4.3   Severability. If one or more provisions of this Agreement are
held to be unenforceable under applicable law, such provision shall be excluded
from this Agreement and the balance of the Agreement shall be interpreted as if
such provision were so excluded and shall be enforceable in accordance with its
terms.

            4.4   Waivers and Amendments; Non-Contractual Remedies; Preservation
of Remedies. This Agreement may be amended, superseded, cancelled, renewed or
extended, and the terms hereof may be waived, only by a written instrument
signed by all of the parties hereto or, in the case of a waiver, by the party
waiving compliance. No delay on the part of any party in exercising any right,
power or privilege hereunder shall operate as a waiver thereof, nor shall any
waiver on the part of such party of any such right, power or privilege, or any
single or partial exercise of any such right, power or privilege, preclude any
further exercise thereof or the exercise of any other such right, power or
privilege.

            4.5   Governing Law. This Agreement shall be governed by and
construed under the laws of the State of New York without regard to choice of
law principles.

            4.6   Further Assurances. Each party shall, at the request of
another party, at any time and from time to time following the Closing promptly
execute and deliver, or cause to be executed and delivered, all such further
instruments and take all such further action as each party may reasonably
request to confirm or carry out the provisions and intent of this Agreement.

            4.7   Counterparts. This Agreement may be executed in counterparts,
each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument.

            4.8   Delivery of Warrant. The Company hereby covenants to deliver
to each Investor the Warrant on the earlier of (i) the funding of the remaining
$14,500,000 in connection with the Financing or (ii) December 17, 2007.


                           [-Signature Page Follows-]


                                       4


      IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date first above written.

                                        THE COMPANY:

                                        BLUEFIRE ETHANOL FUELS, INC.

                                        By: /s/ Arnold R. Klann
                                            -------------------------
                                            Name: Arnold R. Klann
                                            Title: Chairman & CEO


                                        INVESTORS

                                        QUERCUS TRUST

                                        By:
                                            -------------------------
                                            Name:
                                            Title:


                                        /s/ James G. Speirs
                                        -----------------------------
                                        James G. Speirs


                                       5


      IN WITNESS WHEREOF, THE PARTIES HAVE EXECUTED THIS AGREEMENT AS OF THE
DATE FIRST ABOVE WRITTEN.

                                        THE COMPANY:

                                        BLUEFIRE ETHANOL FUELS, INC.

                                        By:
                                            -------------------------
                                            Name:
                                            Title:


                                        INVESTORS

                                        QUERCUS TRUST


                                        BY: /s/ David Gelbaum
                                            -------------------------
                                            NAME: David Gelbaum
                                            TITLE: Trustee


                                        /s/ James G. Speirs
                                        -----------------------------
                                        James G. Speirs


                                       6


                                                                      Schedule A

                              SCHEDULE OF INVESTORS

                                  COMMON STOCK
                                  ------------

                                                               Aggregate
Name                              No. of Shares              Purchase Price
-------------------------  --------------------------  -------------------------

Quercus Trust                        185,185                   $500,000

James G. Speirs                       74,074                   $200,000

James G. Speirs SEP IRA              111,111                   $300,000
                           --------------------------  -------------------------
Total                                370,370                 $1,000,000




                                    WARRANTS
                                    --------

Name                     No. of Warrants      Exercise Price     Exercise Term
---------------------  -------------------  ------------------  ----------------

Quercus Trust                185,185               $2.90             5 Years

James G. Speirs               74,074               $2.90             5 Years

James G. Speirs SEP          111,111               $2.90             5 Years
IRA                    -------------------  ------------------  ----------------

Total                        370,370




                                       7




                                   EXHIBIT C

                         SECURITIES PURCHASE AGREEMENT
                         -----------------------------


      THIS SECURITIES PURCHASE AGREEMENT (this "AGREEMENT") is made as of the
14th day of December 2007, by and among BLUEFIRE ETHANOL FUELS, INC., a Nevada
corporation (the "COMPANY") and Quercus Trust, a ___________ (the "INVESTOR").

      WHEREAS, the Company, the Investor, James G. Speirs, James G. Speirs SEP
IRA (the "NEW INVESTORS") entered into a single private placement financing to
be funded in two tranches (collectively, the "FINANCING"), whereby the New
Investors agreed to purchase from the Company and the Company agreed to issue to
the New Investors shares of common stock and warrants in the Company for an
aggregate purchase price of $15,500,000;

      WHEREAS, the first tranche in the amount of $1,000,000 was funded on
December 3, 2007;

      WHEREAS, the Company and the Investor desire to fund the second tranche on
the date hereof in the amount of $14,500,000.

      NOW, THEREFORE, in consideration of the mutual covenants herein contained,
and for such other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, the parties hereto hereby agree as follows:

      SECTION 1.  Purchase and Sale of the Shares.

            1.1   SALE OF SHARES. Subject to the terms and conditions of this
      Agreement, at the Closing (as hereafter defined), the Company will issue,
      sell and deliver to the Investor, and the Investor will purchase from the
      Company 5,370,370 shares of the Company's common stock (the "SHARES") at a
      purchase price of $2.70 per share (the "PURCHASE PRICE").

            1.2   ISSUANCE OF WARRANTS. Concurrently with the sale of the Shares
      by the Company and the purchase of the Shares by the Investor, the
      Investor will receive a warrant (the "WARRANT") to purchase 5,370,370
      Shares of common stock of the Company (the "WARRANT SHARES") at a purchase
      price of $2.90 per share. The Warrants shall have a term of five (5)
      years.

            1.3   CLOSING. The closing of the purchase and sale of the Shares
      and Warrants (the "CLOSING") will take place at the offices of Seward &
      Kissel LLP, located at One Battery Park Plaza, New York, New York, 10004,
      at 10:00 am, New York time on the date hereof or on such other date or at
      such other place as the parties hereto shall mutually agree (the date of
      the Closing is hereinafter referred to as the "CLOSING DATE"). At the
      Closing or promptly thereafter, the Company will deliver to the Investor a
      stock certificate or certificates dated the Closing Date for the number of
      Shares the Investor has agreed to purchase and registered in such name and
      in such denominations as the Investor requests and a Warrant on the terms
      set forth in Section 1.2 above, and the Investor will pay to the Company
      the Purchase Price by certified check or wire transfer of immediately
      available funds.

      SECTION 2.  REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY. The
Company hereby represents, warrants and covenants to the Investor that:



            2.1   CORPORATE EXISTENCE. The Company is a corporation duly
      organized, validly existing and in good standing under the laws of the
      state of Nevada and has all requisite corporate power to own, lease and
      operate its properties and assets and to conduct its business as it is now
      being conducted.

            2.2   SUBSIDIARIES. Each Subsidiary of the Company is a corporation
      duly incorporated, validly existing and in good standing under the laws of
      its jurisdiction of organization and has the requisite corporate power to
      own, lease and operate its properties and assets and to conduct its
      business as it is now being conducted. For the purposes of this Agreement,
      "SUBSIDIARY" shall mean any corporation or other entity of which at least
      a majority of the securities or other ownership interest having ordinary
      voting power (absolutely or contingently) for the election of directors or
      other Persons performing similar functions are at the time owned directly
      or indirectly by the Company and/or any of its other Subsidiaries.

            2.3   CORPORATE POWER. The Company has the requisite legal and
      corporate power and authority to enter into, issue and perform this
      Agreement and the Warrants in accordance with the terms hereof and
      thereof. The execution, delivery and performance of this Agreement and the
      Warrants by the Company and the consummation by it of the transactions
      contemplated hereby and thereby have been duly and validly authorized by
      all necessary corporate action. When executed and delivered by the
      Company, this Agreement and the Warrants shall constitute valid and
      binding obligations of the Company enforceable against the Company in
      accordance with its terms, except as such enforceability may be limited by
      applicable bankruptcy, reorganization, moratorium, liquidation,
      conservatorship, receivership or similar laws relating to, or affecting
      generally the enforcement of, creditor's rights and remedies or by other
      equitable principles of general application

            2.4   NO CONFLICTS. The execution, delivery and performance of this
      Agreement and the consummation by the Company of the transactions
      contemplated hereby, do not and will not (i) violate or conflict with any
      provision of the Company's certificate of incorporation or bylaws, each as
      amended to date, or any Subsidiary's comparable charter documents, (ii)
      conflict with, or constitute a default (or an event which with notice or
      lapse of time or both would become a default) under, or give to others any
      rights of termination, amendment, acceleration or cancellation of, any
      material agreement, mortgage, deed of trust, indenture, note, bond,
      license, lease agreement, instrument or obligation to which the Company or
      any of its Subsidiaries is a party or by which the Company or any of its
      Subsidiaries' respective properties or assets are bound, or (iii) result
      in a violation of any federal, state, local or foreign statute, rule,
      regulation, order, judgment or decree (including federal and state
      securities laws and regulations) applicable to the Company or any of its
      Subsidiaries or by which any property or asset of the Company or any of
      its Subsidiaries are bound or affected.

            2.5   NO CONSENTS. Neither the Company nor any Subsidiary is
      required to obtain any consent, authorization or order of, or make any
      filing or registration with, any court, governmental agency or any
      regulatory or self-regulatory agency or any other Person in order for it
      to execute, deliver or perform any of its obligations under or
      contemplated by this Agreement in accordance with the terms hereof, except
      for those consents, authorizations, orders, filings and registrations
      previously made or obtained and those filings which are required to be
      made under federal or state securities laws that, pursuant to such laws,
      may be made after the date hereof.

                                       2


            2.6   TITLE TO PROPERTIES. Except as set forth in the Public
      Filings, each of the Company and the Subsidiaries has good and valid title
      to all of its real and personal property, free and clear of any mortgages,
      pledges, charges, liens, security interests or other encumbrances. Any
      leases of the Company and each of its Subsidiaries are valid and
      subsisting and in full force and effect.

            2.7   INSURANCE. The Company and the Subsidiaries are insured by
      insurers of recognized financial responsibility against such losses and
      risks and in such amounts as management of the Company believes to be
      prudent and customary in the businesses in which the Company and its
      Subsidiaries are engaged. Neither the Company nor any such Subsidiary has
      been refused any insurance coverage sought or applied for and neither the
      Company nor any such Subsidiary has any reason to believe that it will not
      be able to renew its existing insurance coverage as and when such coverage
      expires or to obtain similar coverage from similar insurers as may be
      necessary to continue its business at a cost that would not have a
      Material Adverse Effect.

            2.8   LEGAL PROCEEDINGS. Except as set forth in the Public Filings,
      (i) there is no action, suit, claim, investigation, arbitration, alternate
      dispute resolution proceeding or other proceeding pending or, to the
      knowledge of the Company, threatened against the Company or any Subsidiary
      which questions the validity of this Agreement or any of the transactions
      contemplated hereby or any action taken or to be taken pursuant hereto,
      (ii) there is no material action, suit, claim, investigation, arbitration,
      alternate dispute resolution proceeding or other proceeding pending or, to
      the knowledge of the Company, threatened against or involving the Company,
      any Subsidiary or any of their respective properties or assets and (iii)
      there are no material outstanding orders, judgments, injunctions, awards
      or decrees of any court, arbitrator or governmental or regulatory body
      against the Company or any Subsidiary or any officers or directors of the
      Company or Subsidiary in their capacities as such.

            2.9   SECURITIES LAW. In reliance on the investment representations
      made by the Investor, the offer, issuance, sale and delivery of the Shares
      and Warrants, as provided in this Agreement, are exempt from the
      registration requirements of the Securities Act of 1933, as amended (the
      "SECURITIES ACT"), and all applicable state securities laws.

            2.10  INTELLECTUAL PROPERTY. The Company and the Subsidiaries own or
      possess adequate rights or licenses to use all trademarks, service marks,
      and all applications and registrations therefor, trade names, patents,
      patent rights, copyrights, original works of authorship, inventions,
      licenses, approvals, governmental authorizations, trade secrets and other
      intellectual property rights, (collectively "INTELLECTUAL PROPERTY
      RIGHTS") necessary to conduct their respective businesses as now
      conducted. Except as disclosed in the Public Filings, none of the
      Company's Intellectual Property Rights have expired or terminated, or are
      expected to expire or terminate, within two years from the date of this
      Agreement. The Company does not have any knowledge, after reasonable
      inquiry, of any material infringement by the Company or its Subsidiaries
      of Intellectual Property Rights of others. There is no material claim,
      action or proceeding pending, or to the knowledge of the Company, being
      threatened, against the Company or its Subsidiaries regarding its
      Intellectual Property Rights. The Company is unaware of any material facts
      or circumstances which might give rise to any of the foregoing
      infringements or claims, actions or proceedings. The Company and its
      Subsidiaries have taken reasonable security measures to protect the
      secrecy, confidentiality and value of all of their material Intellectual
      Property Rights.

                                       3


            2.11  REPORTS; FINANCIAL STATEMENTS. The Company's Annual Report on
      Form 10-KSB for the year ended December 31, 2006 and Quarterly Reports on
      Form 10-QSB for the quarters ended March 31, 2007, June 30, 2007 and
      September 30, 2007 (the "REPORTS") have been filed with the Securities and
      Exchange Commission (the "SEC") and the Reports complied in all material
      respects with the rules of the SEC applicable to such Reports on the date
      filed with the SEC, and to the Company's best knowledge, the Reports did
      not contain, on the date of filing with the SEC, any untrue statement of a
      material fact, or omit to state any material fact necessary to make the
      statements therein, in light of the circumstances in which they were made,
      not materially misleading. All of the consolidated financial statements
      included in the Reports (the "COMPANY FINANCIAL STATEMENTS"): (a) have
      been prepared from and on the basis of, and are in accordance with, the
      books and records of the Company and with generally accepted accounting
      principles ("GAAP") applied on a basis consistent with prior accounting
      periods; (b) fairly and accurately present in all material respects the
      consolidated financial condition of the Company as of the date of each
      such Company Financial Statement and the results of its operations for the
      periods therein specified; and (c) in the case of the annual financial
      statements, are accompanied by the audit opinion of the Company's
      independent public accountants. Except as set forth in the Company
      Financial Statements, as of the date hereof, Company has no liabilities
      other than (x) liabilities which are reflected or reserved against in the
      Company Financial Statements and which remain outstanding and undischarged
      as of the date hereof, (y) liabilities arising in the ordinary course of
      business of the Company since September 30, 2007, or (z) which were not
      required by generally accepted accounting principles to be reflected or
      reserved on the Company Financial Statements. Since September 30, 2007,
      there has not been any event or change which has had a Material Adverse
      Effect (as hereinafter defined) and Company has no actual knowledge of any
      event or circumstance that would reasonably be expected to result in such
      a Material Adverse Effect. As used herein, "MATERIAL ADVERSE EFFECT" shall
      mean a material adverse effect on (i) the Company, (ii) its consolidated
      results of operations, assets, or financial condition, (iii) its ability
      to perform its obligations under this Agreement or (iv) the Shares or the
      Warrant Shares, PROVIDED HOWEVER, that a Material Adverse Effect shall not
      include facts, circumstances, events, changes, effects or occurrences (i)
      affecting the United States or global economy or capital or financial
      markets or the ethanol market generally which do not materially
      disproportionately affect the Company, (ii) resulting from changes in
      laws, regulations or GAAP, or in the authoritative interpretations thereof
      or in regulatory or interpretive guidance related thereto which do not
      materially disproportionately affect the Company, (iii) resulting from
      earthquakes or similar catastrophes, or acts of war, sabotage, terrorism,
      military action or any escalation or worsening thereof which do not
      materially disproportionately affect the Company, or (iv) resulting from
      this Agreement, the announcement thereof and the transactions contemplated
      hereby.

                                       4


            2.12  THE SHARES. The Shares, when issued, sold and delivered in
      accordance with the terms hereof for the consideration expressed herein,
      will be duly and validly issued, fully paid and nonassessable and free and
      clear of all liens, security interests, options, charges, pledges and
      encumbrances.

            2.13  THE WARRANTS. The Warrants when issued and delivered will be
      duly and validly issued and will be free of all liens and restrictions on
      transfer other than under applicable securities laws..

            2.14  THE WARRANT SHARES. The Warrant Shares have been duly reserved
      for issuance by the Company in sufficient number to cover the exercise of
      all of the Warrants. The issuance of the Warrant Shares upon exercise of
      the Warrants has been duly authorized by the Company and the Warrant
      Shares when delivered in accordance with the Warrant, will be validly
      issued, fully paid and non-assessable, and free of all liens and
      restrictions on transfer other than under applicable securities laws.

            2.15  BROKERS' OR FINDERS' FEES. Except for Ardour Capital
      Investment, LLC ("ARDOUR"), no broker, finder or similar agent has been
      employed by or on behalf of the Company, and no Person or entity with
      which the Company has had any dealings or communications of any kind is
      entitled to any brokerage commission, finder's fee or any similar
      compensation, in connection with this Agreement or the transactions
      contemplated hereby.

            2.16  NO OTHER REPRESENTATIONS. Except as and to the extent set
      forth in this Section 2, the Company makes no representations or
      warranties whatsoever to the Investor and hereby disclaims all liability
      and responsibility for any representation, warranty, statement, or
      information not included herein that was made, communicated, or furnished
      (orally or in writing) to the Investor or its representatives (including
      any opinion, information, projection, or advice that may have been or may
      be provided to the Investor by any director, officer, employee, agent,
      consultant, or representative of the Company or any of is Subsidiaries).

      SECTION 3.  REPRESENTATIONS AND WARRANTIES OF THE Investor. The Investor
hereby represents and warrants that:

            3.1   CORPORATE EXISTENCE. The Investor is duly organized, validly
      existing and in good standing under the laws of its jurisdiction of
      organization and has all requisite corporate or other power to own, lease
      and operate its properties and assets and to conduct its business as it is
      now being conducted..

            3.2   CORPORATE POWER. The Investor has the requisite legal,
      corporate or other power and authority to enter into, issue and perform
      this Agreement in accordance with the terms hereof. The execution,
      delivery and performance of this Agreement by the Investor and the
      consummation by it of the transactions contemplated hereby have been duly
      and validly authorized by all necessary corporate or other action. When
      executed and delivered by the Investor, this Agreement shall constitute
      valid and binding obligations of the Investor enforceable against the
      Investor in accordance with its terms, except as such enforceability may
      be limited by applicable bankruptcy, reorganization, moratorium,
      liquidation, conservatorship, receivership or similar laws relating to, or
      affecting generally the enforcement of, creditor's rights and remedies or
      by other equitable principles of general application.

                                       5


            3.3   SECURITIES LAW. The Investor is an "accredited investor" as
      defined in Rule 501(a) promulgated under the Securities Act and has such
      knowledge and experience in financial and business matters that it is
      capable of evaluating the merits and risks of the transactions
      contemplated under this Agreement. The Investor is acquiring the Shares
      and Warrants solely for investment purposes, with no intention of
      distributing or reselling any of the Shares or Warrants or any interest
      therein. The Investor's financial condition is such that it is able to
      bear all economic risks of investment in the Shares and Warrants,
      including a complete loss of its investment. The Company has provided the
      Investor with adequate access to financial and other information
      concerning the Company as requested and the Investor has had the
      opportunity to ask questions of and receive answers from the Company
      concerning the transactions contemplated by this Agreement and to obtain
      therefrom any additional information necessary to make an informed
      decision regarding an investment in the Company. The Investor is aware
      that the Shares are not registered under the Securities Act and will be
      endorsed with transfer restriction legends, and that neither the Shares
      nor any interest therein may be sold, pledged, or otherwise transferred
      unless the Shares are registered under the Securities Act or qualify for
      an exemption under the Securities Act.

            3.4   NO CONFLICTS. The execution, delivery and performance of this
      Agreement and the consummation by the Investor of the transactions
      contemplated hereby, do not and will not (i) violate or conflict with any
      provision of any Investor's organizational documents, each as amended to
      date, (ii) conflict with, or constitute a default (or an event which with
      notice or lapse of time or both would become a default) under, or give to
      others any rights of termination, amendment, acceleration or cancellation
      of, any material agreement, mortgage, deed of trust, indenture, note,
      bond, license, lease agreement, instrument or obligation to which any
      Investor is a party or by which any of its respective properties or assets
      are bound, or (iii) result in a violation of any federal, state, local or
      foreign statute, rule, regulation, order, judgment or decree (including
      federal and state securities laws and regulations) applicable to the
      Investor or by which any property or asset of the Investor are bound or
      affected.

            3.5   BROKERS' OR FINDERS' FEES. No broker, finder or similar agent
      has been employed by or on behalf of the Investor, and no Person or entity
      with which the Investor has had any dealings or communications of any kind
      is entitled to any brokerage commission, finder's fee or any similar
      compensation, in connection with this Agreement or the transactions
      contemplated hereby.

            3.6   CERTAIN TRADING ACTIVITIES. The Investor has not directly or
      indirectly, nor has any Person acting on behalf of or pursuant to any
      understanding with the Investor, engaged in any transactions in the
      securities of the Company (including, without limitations, any short sales
      involving the Company's securities) since the time that such Investor was
      first contacted by the Company or Ardour regarding the investment in the
      Company contemplated by this Agreement. The Investor covenants that
      neither it nor any Person acting on its behalf or pursuant to any
      understanding with it will engage in any transactions in the securities of
      the Company (including short sales) prior to the time that the
      transactions contemplated by this Agreement are publicly disclosed by the
      Company. The Investor has maintained, and covenants that until such time
      as the transactions contemplated by this Agreement are publicly disclosed
      by the Company the Investor will maintain, the confidentiality of any
      disclosures made to it in connection with this transaction (including the
      existence and terms of this transaction).

                                       6


            3.7   LIMITED OWNERSHIP. The purchase by the Investor of the
      securities issuable to it at the Closing will not result in the Investor
      (individually or together with any other Person with whom the Investor has
      identified, or will have identified, itself as part of a "group" in a
      public filing made with the SEC involving the Company's securities)
      acquiring, or obtaining the right to acquire, beneficial ownership in
      excess of 19.999% of the outstanding shares of common stock or the voting
      power of the Company on a post transaction basis that assumes that the
      Closing shall have occurred. The Investor does not presently intend to,
      alone or together with others, make a public filing with the SEC to
      disclose that it has (or that it together with such other Persons have)
      acquired, or obtained the right to acquire, as a result of the Closing
      (when added to any other securities of the Company that it or they then
      own or have the right to acquire), beneficial ownership in excess of
      19.999% of the outstanding shares of common stock or the voting power of
      the Company on a post transaction basis that assumes that the Closing
      shall have occurred.

      SECTION 4.  CONDITIONS TO CLOSING. The following are conditions to Closing
which shall be deemed satisfied upon delivery by the Company of the certificates
representing the Shares and the Warrants and delivery by the Investor of the
Purchase Price:

            4.1   TERMINATION OF SECURITY INTERESTS/UCC FILINGS. Aurarian
      Capital Partners II, L.P. ("AURARIAN CAPITAL") and Aurarian Offshore Ltd.
      ("AURARIAN OFFSHORE") shall have agreed to release any security interests
      they have in the assets of the Company and its Subsidiaries and the
      Company shall have filed UCC termination statements extinguishing any
      security interests.

            4.2   CONVERSION OPTION. Each of Aurarian Capital and Aurarian
      Offshore shall have fully converted their respective Senior Secured
      Convertible Promissory Notes with an aggregate principle amount of
      $2,000,000 at a conversion price of $2.90 into common stock of the Company
      (the "AURARIAN FINANCING").

      SECTION 5.  COVENANTS.

            5.1   PARTICIPATIONS. Until the second anniversary from the Closing
      Date, the Company covenants to grant the Investor the right to purchase
      its pro rata share of any shares of future offerings (other than Excluded
      Issuances) of equity securities (or warrants or securities convertible
      into equity securities) of the Company that will enable it to maintain its
      fully diluted percentage ownership of the Company at the offering price or
      the price being paid by a third party, as applicable. "EXCLUDED ISSUANCES"
      shall mean any equity securities (or warrants or securities convertible
      into equity securities) issued (i) to employees, officers, directors,
      contractors, consultants or advisers approved by the Board of Directors of
      the Company (the "BOARD"), (ii) to parties that are strategic partners
      investing in connection with a commercial relationship, or providing the
      Company with equipment leases, real property leases, loans, credit lines,
      guaranties or similar transactions approved by the Board, (iii) in
      connection with a merger or acquisition or in connection with a joint
      venture or other strategic or commercial relationship approved by the
      Board, (iv) upon the exercise of currently outstanding convertible
      securities, options and warrants, and (v) in connection with any public
      offering.

                                       7


            5.2   OPTION RESTRICTIONS. Until all of the Shares are subject to an
      effective registration statement, the Company shall not issue shares,
      warrants or options to any Affiliates such that after giving effect to
      such issuance, the number of shares held by such Affiliates have increased
      by greater than ten percent (10%) over the number of outstanding shares of
      the Company held by Affiliates, in each case on a fully diluted basis, as
      of Closing Date.

      SECTION 6.  REGISTRATION RIGHTS.

            6.1   REGISTRATION PROCEDURES AND EXPENSES. The Company shall:

            (a)   within 45 days of the Closing Date (the "FILING DEADLINE"),
prepare and file with the SEC a Registration Statement (the "INITIAL
REGISTRATION STATEMENT") relating to the resale of the sum (the "REQUIRED
REGISTRATION AMOUNT") of (i) the number of Shares and Warrant Shares issued to
the New Investors and (ii) the number of shares of common stock and warrant
shares of the Company issued to Aurarian pursuant to the Aurarian Financing
(collectively, the "REGISTRABLE SECURITIES"). The Initial Registration Statement
shall be on Form SB-2 (or on another appropriate form). Notwithstanding anything
herein to the contrary, if the SEC prevents the Company from including the
Required Registration Amount of Registrable Securities on the Initial
Registration Statement due to limitations on the use of Rule 415 of the
Securities Act or otherwise for the resale of the Registrable Securities by the
New Investors and Aurarian (the Registrable Securities not included on such
Registration Statement, the "CUTBACK SHARES"), the Initial Registration
Statement shall register the resale of a number of Registrable Securities which
is equal to the maximum number of shares as is permitted by the SEC. In such
event, the number of Registrable Securities to be registered for the New
Investors and Aurarian in the Initial Registration Statement shall be reduced
PRO RATA among all New Investors and Aurarian. With respect to the Cutback
Shares, the Company shall file additional registration statements (each an
"ADDITIONAL REGISTRATION STATEMENT" and with the Initial Registration Statement,
the "REGISTRATION STATEMENT") successively trying to register the maximum number
of remaining Cutback Shares until all of the Required Registration Amount of
Registrable Securities have been registered with the SEC.;

            (b)   use its reasonable commercial efforts, subject to receipt of
necessary information from the New Investors and Aurarian, to cause the SEC to
declare the Initial Registration Statement effective within 150 days after the
Closing Date (or ten business days after receipt of notice of no review by the
SEC) (the "EFFECTIVE DEADLINE");

            (c)   promptly prepare and file with the SEC such amendments and
supplements to any Registration Statement filed pursuant to this Section 6.1 and
the prospectus used in connection therewith as may be necessary to keep such
Registration Statement effective until the earliest of (i) such time as all of
the Registrable Securities have been sold pursuant to the Registration
Statement, (ii) two years or (iii) such time all of the Registrable Securities
become eligible for resale without volume limitations pursuant to Rule 144
(including for purposes of this Agreement, any successor rule that may be
adopted following the date hereof) under the Securities Act or any other rule of
similar effect (the "EFFECTIVENESS PERIOD");

                                       8


            (d)   furnish to the New Investors and Aurarian with respect to the
Registrable Securities registered under any Registration Statement (and to each
underwriter, if any, of such Registrable Securities) such number of copies of
prospectuses and such other documents as the New Investors may reasonably
request, in order to facilitate the public sale or other disposition of all or
any of the Registrable Securities by the New Investors and Auraruan;

            (e)   bear all expenses in connection with the procedures in
paragraphs (a) through (f) of this Section 6.1 and the registration of the
Registrable Securities pursuant to any Registration Statement, other than fees
and expenses, if any, of counsel or other advisers to the New Investors and
Aurarian or underwriting discounts, brokerage fees and commissions incurred by
the New Investors or Aurarian, if any in connection with the offering of the
shares pursuant to any Registration Statement;

            (f)   in order to enable the New Investors to sell the Registrable
Securities under Rule 144 to the Securities Act ("RULE 144"), for a period of
two years from the Closing Date, use its commercially reasonable efforts to
comply with the requirements of Rule 144, including without limitation, use its
commercially reasonable efforts to comply with the requirements of Rule 144 with
respect to public information about the Company and timely file all reports
required to be filed by the Company under the Exchange Act;

            6.2   DELAY IN FILING OR EFFECTIVENESS OF REGISTRATION STATEMENT.
(a) If (i) the Initial Registration Statement is not filed by the Company with
the SEC on or prior to the Filing Deadline, then for each day following the
Filing Deadline, until but excluding the date the Initial Registration Statement
is filed, the Company shall pay the New Investors with respect to any such
failure, as liquidated damages and not as a penalty, an amount per 30-day period
equal to 1.0% of the purchase price paid by such New Investors for its Shares
pursuant to this Agreement (on a daily basis over such period) (the "FILING
LIQUIDATED DAMAGES") or (ii) if the Initial Registration Statement is not
declared effective by the SEC by the Effective Deadline, then for each day
following the Effective Deadline, until but excluding the date that is the
earlier of the date the SEC declares the Initial Registration Statement
effective or the 30th day after the Effective Deadline, the Company shall pay
the New Investors with respect to any such failure, as liquidated damages and
not as a penalty, an amount for such period equal to 0.50% of the purchase price
paid by such New Investors for its Shares pursuant to this Agreement (pro rata)
(the "150 DAY LIQUIDATED DAMAGES") or (iii) if the Initial Registration
Statement is not declared effective by the SEC by the 180 Day Effective
Deadline, then for each day following the 180 Day Effective Deadline, until but
excluding the date the SEC declares the Initial Registration Statement
effective, the Company shall pay the New Investors with respect to any such
failure, as liquidated damages and not as a penalty, an amount per 30-day period
equal to 1.0% of the purchase price paid by such New Investors for its Shares
pursuant to this Agreement (pro rata on a 30 day basis) (the "180 Day LIQUIDATED
DAMAGES," and together with the Filing Liquidated Damages and the 150 Day
Liquidated Damages, the "Liquidated Damages"). Notwithstanding the foregoing
provisions, in no event shall the Company be obligated to pay any Liquidated
Damages pursuant to this Section 6.2 (i) to more than one New Investor in
respect of the same Shares or Warrants for the same period of time, (ii) with
respect to any Cutback Shares, (iii) with respect to the Warrants or any Warrant
Shares, (iv) in respect of any Shares that are eligible to be sold by any New
Investor pursuant to Rule 144 and (v) of more than 5.0% of the Purchase Price,
in the aggregate.

                                       9


            (g)   Notwithstanding anything herein to the contrary, the Company
in its sole discretion may pay any Liquidated Damages in either (i) cash or (ii)
additional shares of common stock. Such additional shares shall be valued by the
average VWAP five (5) trading days prior to when such Liquidated Damages shall
be paid.

      SECTION 7.  DEFINITIONS.

            7.1   DEFINED TERMS USED IN THIS AGREEMENT. In addition to the terms
      defined above, the following terms used in this Agreement shall be
      construed to have the meanings set forth or referenced below:

            "AFFILIATE" means, with respect to any Person (i) a director,
officer or shareholder of such Person, (ii) a spouse, parent, sibling or
descendant of such Person (or spouse, parent, sibling or descendant of any
director or executive officer of such Person), and (iii) any other Person that,
directly or indirectly through one or more intermediaries, controls, or is
controlled by, or is under common control with, such Person.

            "150 DAY LIQUIDATED DAMAGES" has the meaning set forth in Section
6.2.

            "180 DAY EFFECTIVE DEADLINE" shall mean the day that is 180 days
after the Closing Date.

            "180 DAY LIQUIDATED DAMAGES" has the meaning set forth in Section
6.2.

            "ADDITIONAL REGISTRATION STATEMENT" has the meaning set forth in
Section 6.1(a).

            "AGREEMENT" has the meaning set forth in the preamble.

            "AURARIAN" means Aurarian Capital and Aurarian Offshore.

            "AURARIAN CAPITAL" has the meaning set forth in Section 4.1.

            "AURARIAN FINANCING" has the meaning set forth in Section 4.2.

            "AURARIAN OFFSHORE" has the meaning set forth in Section 4.1.

            "BOARD" has the meaning set forth in Section 5.1.

            "CLOSING" has the meaning set forth in Section 1.3.

            "CLOSING DATE" has the meaning set forth in Section 1.3.

                                       10


            "COMPANY" has the meaning set forth in the preamble.

            "COMPANY FINANCIAL STATEMENTS" has the meaning set forth in Section
2.11.

            "CUTBACK SHARES" has the meaning set forth in Section 6.1(a).

            "EFFECTIVE DEADLINE" has the meaning set forth in Section 6.1(b).

            "EFFECTIVENESS PERIOD" has the meaning set forth in Section 6.1(c).

            "EXCHANGE ACT" means the Securities and Exchange Act of 1934, as
amended and the rules and regulations promulgated thereunder.

            "EXCLUDED ISSUANCES" has the meaning set forth in Section 5.1.

            "FILING DEADLINE" has the meaning set forth in Section 6.1(a).

            "FILING LIQUIDATED DAMAGES" has the meaning set forth in Section
6.2.

            "FINANCING" has the meaning set forth in the first recital.

            "GAAP" has the meaning set forth in Section 2.11.

            "INITIAL REGISTRATION AMOUNT" has the meaning set forth in Section
6.1(a).

            "INTELLECTUAL PROPERTY RIGHTS" has the meaning set forth in Section
2.10.

            "INVESTOR" has the meaning set forth in the preamble.

            "LIQUIDATED DAMAGES" has the meaning set forth in Section 6.2.

            "MATERIAL ADVERSE EFFECT" has the meaning set forth in Section 2.11.

            "NEW INVESTORS" has the meaning set forth in the first recital.

            "PERSON" means an individual, partnership, corporation, limited
liability company, association, trust, unincorporated organization, or any other
company or entity or a government or agency or political subdivision thereof.

            "PUBLIC FILING" means all forms, Reports, schedules, statements,
exhibits and other documents or information filed with the SEC pursuant to the
Exchange Act or the Securities Act.

            "PURCHASE PRICE" has the meaning set forth in Section 1.1.

            "REGISTRABLE SECURITIES" has the meaning set forth in Section
6.1(a).

            "REGISTRATION STATEMENT" has the meaning set forth in Section
6.1(a).

            "REPORTS" has the meaning set forth in Section 2.11.

                                       11


            "REQUIRED REGISTRATION AMOUNT" has the meaning set forth in Section
6.1(a).

            "RULE 144" has the meaning set forth in Section 6.1(f).

            "SEC" has the meaning set forth in Section 2.11.

            "SECURITIES ACT" has the meaning set forth in Section 2.9.

            "SENIOR SECURED CONVERTIBLE PROMISSORY NOTES" means the Senior
Secured Convertible Promissory Notes, dated August 21, 2007, issued by the
Company to each of Aurarian Capital and Aurarian Offshore.

            "SHARES" has the meaning set forth in the third recital.

            "SUBSIDIARY" has the meaning set forth in Section 2.2.

            "WARRANTS" has the meaning set forth in Section 1.2.

            "WARRANT SHARES" has the meaning set forth in Section 1.2.

      SECTION 8.  MISCELLANEOUS.

            8.1   SUCCESSORS AND ASSIGNS. Except as otherwise provided herein,
      the terms and conditions of this Agreement shall inure to the benefit of
      and be binding upon the respective successors and assigns of the parties.

            8.2   ENTIRE AGREEMENT. This Agreement constitutes the full and
      entire understanding and agreement between the parties hereto with respect
      to the subject matter hereof and supersedes all prior agreements, written
      or oral, with respect thereto.

            8.3   SEVERABILITY. If one or more provisions of this Agreement are
      held to be unenforceable under applicable law, such provision shall be
      excluded from this Agreement and the balance of the Agreement shall be
      interpreted as if such provision were so excluded and shall be enforceable
      in accordance with its terms.

            8.4   WAIVERS AND AMENDMENTS; NON-CONTRACTUAL REMEDIES; PRESERVATION
      OF REMEDIES. This Agreement may be amended, superseded, cancelled, renewed
      or extended, and the terms hereof may be waived, only by a written
      instrument signed by all of the parties hereto or, in the case of a
      waiver, by the party waiving compliance. No delay on the part of any party
      in exercising any right, power or privilege hereunder shall operate as a
      waiver thereof, nor shall any waiver on the part of such party of any such
      right, power or privilege, or any single or partial exercise of any such
      right, power or privilege, preclude any further exercise thereof or the
      exercise of any other such right, power or privilege.

            8.5   GOVERNING LAW. This Agreement shall be governed by and
      construed under the laws of the State of New York without regard to choice
      of law principles.

                                       12


            8.6   FURTHER ASSURANCES. Each party shall, at the request of
      another party, at any time and from time to time following the Closing
      promptly execute and deliver, or cause to be executed and delivered, all
      such further instruments and take all such further action as each party
      may reasonably request to confirm or carry out the provisions and intent
      of this Agreement.

            8.7   COUNTERPARTS. This Agreement may be executed in counterparts,
      each of which shall be deemed an original, but all of which together shall
      constitute one and the same instrument.






                                       13


      IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date first above written.

                                           THE COMPANY:

                                           BLUEFIRE ETHANOL FUELS, INC.


                                           By: _______________________________
                                               Name:
                                               Title:


                                           INVESTOR

                                           QUERCUS TRUST


                                           By: _______________________________
                                               Name:
                                               Title:




                                       14